USP49 drives malignant progression of esophagogastric junction adenocarcinoma by activating the SHC binding and spindle associated 1 (SHCBP1)/β-catenin/glutathione peroxidase 4 (GPX4) signaling pathway (53). Here, GPX4 is linked to gastroesophageal junction adenocarcinoma.